Dr. Raymond Keith Cross Jr., MD

Dr. Cross practices at GastroIntestinal Diagnostic Center in Baltimore, Maryland.

Dr. Cross' NPI, 1447214507, was assigned on April 14, 2006. Dr. Cross graduated from University of Pittsburgh School of Medicine in 1997. Dr. Cross holds Maryland license D0055909.

Dr. Cross' primary practice is GastroIntestinal Diagnostic Center, at 700 Geipe Road, Suite 220, Baltimore, MD 21228. The practice phone is (410) 242-3636.

Dr. Cross' primary practice is GastroIntestinal Diagnostic Center in Baltimore, Maryland. Dr. Cross is also affiliated with University of Maryland Medical Center. The medical group on file is University of Maryland Medical Center Gastroenterology and Hepatology. Dmand AI also links Dr. Cross to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cross practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Cross' primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Cross is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Cross' licenses on file in 2 states: Maryland and Pennsylvania.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), colonoscopy, fatty liver, gastroenteritis, intestinal or bowel obstruction, irritable bowel syndrome (IBS) and upper GI endoscopy among the conditions Dr. Cross treats.

CMS data shows 386 Medicare services from Dr. Cross across 9 procedure codes in 2024, for 194 Medicare patients. Medicare paid $27,528 for them.

CMS counts 194 Medicare patients who saw Dr. Cross in 2024. The largest group is 65 to 74, with 85 patients. 74% of them have high blood pressure, and 73% have high cholesterol. 22% are also on Medicaid. Their average risk score is 1.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cross' median patient age at 57, with 58% women.

In 2024, Dr. Cross wrote 603 Medicare Part D claims for 129 patients. 59% of them were for generic drugs. CMS names the drug for 430 of them, across 21 drugs with 11 or more claims each, at $3,271,797 in total drug cost. In 2023, CMS named 486 claims across 19 drugs.

Dr. Cross accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cross as offering telehealth. CMS counts 149 procedures of colonoscopy by Dr. Cross, more than 89% of the clinicians it reports for that procedure.

Dmand AI links 231 papers to Dr. Cross, published from 2006 to 2025. 2023 was the busiest year, with 18. The most frequent topics are Inflammatory Bowel Diseases, Crohn Disease and Colitis, Ulcerative. Dr. Cross has published most often in Inflamm Bowel Dis. Dr. Cross' most frequent co-authors are Francis A. Farraye, MD, Sandra Maria Quezada, MD and Sara Nicole Horst, MD.

Dmand AI links Dr. Cross to 10 clinical trials, 3 of them phase 3 studies. Conditions studied include Colitis, Ulcerative, Colitis and Crohn Disease. University of Maryland, Baltimore sponsors the most, 3.

CMS Open Payments shows 668 general payments to Dr. Cross from 34 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 61% of the total. Janssen Pharmaceuticals, Inc paid the most, $141,669. It also lists 11 research payments totaling $83,229 from 2017 to 2025.

Dmand AI lists 3 awards for Dr. Cross, most recently AGA Fellow in 2013.

Dr. Cross graduated from University of Pittsburgh School of Medicine in 1997. Dr. Cross is a member of AGA.

Dr. Cross is in network with 12 carriers, including Aetna, Blue Cross Blue Shield of Michigan and CareFirst BlueCross BlueShield. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.